`
`(31) Joost Louwagie | LinkedIn
`3
`3
`25
`My Network
`Messaging Notifications
`
`Jobs
`
`Home
`
`Me
`
`For Business
`
`Get Premi
`$0
`
`Joost Louwagie
` (He/Him)
`· 3rd
`C-level executive, using an effective collaboration style to go ‘above and
`beyond’ in innovation management in the Biotech/Pharma space.
`Novartis
`
`
`
`Vlerick Business School
`
`Riehen, Basel, Switzerland · Contact info
`500+ connections
`Message
`
`Connect
`
`More
`
`Open to work
`Head and Chief roles
`Show details
`
`About
`I'm energised when leading or coaching teams to high levels of performance. I'm
`comfortable with scale, complexity, and high pace; I enjoy finding solutions to
`complex problems and getting them approved and funded by senior managers. I
`
`believe that an organisation should constantly improve its processes, technologies……see more
`
`Activity
`930 followers
`
`Joost Louwagie commented on a post • 1mo
`Congratulations.
`
`Joost Louwagie commented on a post • 7mo
`Thanks Anne, I second prior comments. Well done and much appreciated.
`
`Show all comments
`
`Experience
`Novartis
`13 yrs 2 mos
`Due Diligence Head, Strategy & Growth / Corporate & Business
`Development
`Full-time
`Jul 2019 - Present · 4 yrs 7 mos
`Basel Area, Switzerland
`
`https://www.linkedin.com/in/joost-louwagie/?originalSubdomain=ch
`
`1/5
`
`Geneoscopy Exhibit 1016, Page 1
`
`
`
`1/10/24, 1:22 PM
`
`(31) Joost Louwagie | LinkedIn
`
`Leading project activities for licensing or divestment of drug compounds to
`Global Transition Excellence Director
`third parties during due diligence and deal implementation.…
`…see more
`Part-time
`Aug 2021 - Jul 2022 · 1 yr
`Basel, Switzerland
`Talent job rotation on 50% basis into the role of Global Transition Excellence
`
`Director. This role manages the transition and integration of external asset……see more
`
`Global Program Director Out-Partnering
`Mar 2018 - Jul 2019 · 1 yr 5 mos
`Basel Area, Switzerland
`Leading all project activities for out-licensing or divestment of drug
`compounds to third parties.
`
`Show all 8 experiences
`
`Vice President Product Development
`OncoMethylome Sciences
`Apr 2005 - Nov 2010 · 5 yrs 8 mos
`Leuven, belgium
`Responsible for alliance management of private and academic product
`
`development collaborations. Member of the management team and VP……see more
`
`Product Development Manager
`Innogenetics
`1993 - 2005 · 12 yrs
`Gent Area, Belgium
`Held various position with increasing responsibility, e.g. as "Senior Scientist",
`
`"Program Manager Infectious Disease" franchise, "Product Development……see more
`
`Education
`Vlerick Business School
`MBA, Executive international MBA
`2004 - 2006
`
`KU Leuven
`Ph.D, Biochemistry
`
`Skills
`Biotechnology
`Endorsed by Susan Bromley and 6 others who are highly skilled at this
`
`Endorsed by 5 colleagues at Novartis
`
`44 endorsements
`
`R&D
`Endorsed by Lieve Declercq and 1 other who is highly skilled at this
`
`Endorsed by 3 colleagues at Novartis
`
`41 endorsements
`
`Show all 44 skills
`
`Recommendations
`
`https://www.linkedin.com/in/joost-louwagie/?originalSubdomain=ch
`
`2/5
`
`Geneoscopy Exhibit 1016, Page 2
`
`
`
`1/10/24, 1:22 PM
`
`(31) Joost Louwagie | LinkedIn
`
`Received
`
`Given
`
`Nothing to see for now
`Recommendations that Joost receives will appear here.
`
`Patents
`METHODS FOR DETECTING EPIGENETIC MODIFICATIONS
`BE PCT/EP2011/056797 · Issued Dec 11, 2011
`See patent
`
`A method of determining the methylation status of a gene, in particular at least
`SYNE1 in a sample, such as a blood sample, in particular a blood plasma or serum…
`Other inventors
`
`IMPROVED URINE SAMPLE COLLECTING AND PROCESSING
`BE PCT/GB2008/002093 · Issued Dec 24, 2008
`See patent
`
`A method for identifying, diagnosing and/or staging or otherwise characterising a
`
`urologic cancer or neoplasia in a subject comprises isolating cell-free DNA from a……see more
`Other inventors
`
`Show all 3 patents
`
`Languages
`Dutch
`Native or bilingual proficiency
`
`English
`Full professional proficiency
`
`Show all 4 languages
`
`Interests
`Companies
`
`Groups
`
`Newsletters
`
`Schools
`
`Novartis
`3,679,373 followers
`Follow
`
`Roche
`3,157,406 followers
`Follow
`
`Show all companies
`
`https://www.linkedin.com/in/joost-louwagie/?originalSubdomain=ch
`
`3/5
`
`Geneoscopy Exhibit 1016, Page 3
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
